Every week, researchers in Boston’s biotech labs tackle threats to life, such as cancer, autoimmune diseases and heart disease, as well as newer threats, such as Zika, forcing scientists to innovate like never before. Their innovations are tied to the creation of better software able to process complicated findings, driving venture capital interest in both research labs and the software being used. Thanks to all the activity in Boston right now, you might assume that any entrepreneurial scientist with a great biotech idea would have no problem starting up, especially in the life sciences center of the country, Kendall Square.
